ArticleClinical drug investigation2025
Cost-Effectiveness of Adding Dapagliflozin and Empagliflozin to Standard Treatment for Diabetic Kidney Disease in China.
Tingting Qiu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it